179 related articles for article (PubMed ID: 31315616)
61. The Compound of Mangiferin-Berberine Salt Has Potent Activities in Modulating Lipid and Glucose Metabolisms in HepG2 Cells.
Wang C; Jiang JD; Wu W; Kong WJ
Biomed Res Int; 2016; 2016():8753436. PubMed ID: 27123455
[TBL] [Abstract][Full Text] [Related]
62. Silent Information Regulator 1 Negatively Regulates Atherosclerotic Angiogenesis via Mammalian Target of Rapamycin Complex 1 Signaling Pathway.
Chen R; Huang Z; Wang J; Chen X; Fu Y; Wang W
Am J Med Sci; 2018 Aug; 356(2):168-176. PubMed ID: 30219159
[TBL] [Abstract][Full Text] [Related]
63. MicroRNA-190b regulates lipid metabolism and insulin sensitivity by targeting IGF-1 and ADAMTS9 in non-alcoholic fatty liver disease.
Xu M; Zheng XM; Jiang F; Qiu WQ
J Cell Biochem; 2018 Jul; 119(7):5864-5874. PubMed ID: 29575055
[TBL] [Abstract][Full Text] [Related]
64. MicroRNA-206 prevents hepatosteatosis and hyperglycemia by facilitating insulin signaling and impairing lipogenesis.
Wu H; Zhang T; Pan F; Steer CJ; Li Z; Chen X; Song G
J Hepatol; 2017 Apr; 66(4):816-824. PubMed ID: 28025059
[TBL] [Abstract][Full Text] [Related]
65. Transcriptional regulation of the hypocretin/orexin gene by NR6A1.
Tanaka S; Kodama T; Nonaka T; Toyoda H; Arai M; Fukazawa M; Honda Y; Honda M; Mignot E
Biochem Biophys Res Commun; 2010 Dec; 403(2):178-83. PubMed ID: 21056546
[TBL] [Abstract][Full Text] [Related]
66. Dihydromyricetin ameliorates oleic acid-induced lipid accumulation in L02 and HepG2 cells by inhibiting lipogenesis and oxidative stress.
Xie C; Chen Z; Zhang C; Xu X; Jin J; Zhan W; Han T; Wang J
Life Sci; 2016 Jul; 157():131-139. PubMed ID: 27265384
[TBL] [Abstract][Full Text] [Related]
67. Eicosapentaenoic Acid Improves Hepatic Metabolism and Reduces Inflammation Independent of Obesity in High-Fat-Fed Mice and in HepG2 Cells.
Albracht-Schulte K; Gonzalez S; Jackson A; Wilson S; Ramalingam L; Kalupahana NS; Moustaid-Moussa N
Nutrients; 2019 Mar; 11(3):. PubMed ID: 30871035
[TBL] [Abstract][Full Text] [Related]
68. nm23 regulates decidualization through the PI3K-Akt-mTOR signaling pathways in mice and humans.
Zhang X; Fu LJ; Liu XQ; Hu ZY; Jiang Y; Gao RF; Feng Q; Lan X; Geng YQ; Chen XM; He JL; Wang YX; Ding YB
Hum Reprod; 2016 Oct; 31(10):2339-51. PubMed ID: 27604954
[TBL] [Abstract][Full Text] [Related]
69. Mulberry anthocyanins inhibit oleic acid induced lipid accumulation by reduction of lipogenesis and promotion of hepatic lipid clearance.
Chang JJ; Hsu MJ; Huang HP; Chung DJ; Chang YC; Wang CJ
J Agric Food Chem; 2013 Jun; 61(25):6069-76. PubMed ID: 23731091
[TBL] [Abstract][Full Text] [Related]
70. Role of salt inducible kinase 1 in high glucose-induced lipid accumulation in HepG2 cells and metformin intervention.
Zhang Y; Takemori H; Wang C; Fu J; Xu M; Xiong L; Li N; Wen X
Life Sci; 2017 Mar; 173():107-115. PubMed ID: 28174122
[TBL] [Abstract][Full Text] [Related]
71. Lycopus lucidus Turcz. ex Benth. Attenuates free fatty acid-induced steatosis in HepG2 cells and non-alcoholic fatty liver disease in high-fat diet-induced obese mice.
Lee MR; Yang HJ; Park KI; Ma JY
Phytomedicine; 2019 Mar; 55():14-22. PubMed ID: 30668424
[TBL] [Abstract][Full Text] [Related]
72. Casein glycomacropeptide-derived peptide IPPKKNQDKTE ameliorates high glucose-induced insulin resistance in HepG2 cells via activation of AMPK signaling.
Song JJ; Wang Q; Du M; Li TG; Chen B; Mao XY
Mol Nutr Food Res; 2017 Feb; 61(2):. PubMed ID: 27506476
[TBL] [Abstract][Full Text] [Related]
73. Inhibition of mitochondrial β-oxidation by miR-107 promotes hepatic lipid accumulation and impairs glucose tolerance in vivo.
Bhatia H; Pattnaik BR; Datta M
Int J Obes (Lond); 2016 May; 40(5):861-9. PubMed ID: 26499439
[TBL] [Abstract][Full Text] [Related]
74. Let-7 represses Nr6a1 and a mid-gestation developmental program in adult fibroblasts.
Gurtan AM; Ravi A; Rahl PB; Bosson AD; JnBaptiste CK; Bhutkar A; Whittaker CA; Young RA; Sharp PA
Genes Dev; 2013 Apr; 27(8):941-54. PubMed ID: 23630078
[TBL] [Abstract][Full Text] [Related]
75. Mammalian target of rapamycin complex 1 and FoxO1 in the transcriptional control of lipolysis and de novo lipogenesis.
Kandror KV
Curr Opin Endocrinol Diabetes Obes; 2017 Oct; 24(5):326-331. PubMed ID: 28841634
[TBL] [Abstract][Full Text] [Related]
76. LXRɑ participates in the mTOR/S6K1/SREBP-1c signaling pathway during sodium palmitate-induced lipogenesis in HepG2 cells.
Zhou Y; Yu S; Cai C; Zhong L; Yu H; Shen W
Nutr Metab (Lond); 2018; 15():31. PubMed ID: 29743930
[TBL] [Abstract][Full Text] [Related]
77. Lipid metabolism, inflammation, and foam cell formation in health and metabolic disorders: targeting mTORC1.
Cheon SY; Cho K
J Mol Med (Berl); 2021 Nov; 99(11):1497-1509. PubMed ID: 34312684
[TBL] [Abstract][Full Text] [Related]
78. Metformin reduces lipid accumulation in HepG2 cells via downregulation of miR-33b.
Zare M; Panahi G; Koushki M; Mostafavi-Pour Z; Meshkani R
Arch Physiol Biochem; 2022 Apr; 128(2):333-340. PubMed ID: 31686542
[TBL] [Abstract][Full Text] [Related]
79. Lipocalin 2 Deficiency Alters Prostaglandin Biosynthesis and mTOR Signaling Regulation of Thermogenesis and Lipid Metabolism in Adipocytes.
Deis J; Lin TY; Bushman T; Chen X
Cells; 2022 May; 11(9):. PubMed ID: 35563840
[TBL] [Abstract][Full Text] [Related]
80. Phosphorylation and recruitment of BAF60c in chromatin remodeling for lipogenesis in response to insulin.
Wang Y; Wong RH; Tang T; Hudak CS; Yang D; Duncan RE; Sul HS
Mol Cell; 2013 Jan; 49(2):283-97. PubMed ID: 23219531
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
